← Evidence map

ReviewDrugs2018

Empagliflozin: A Review in Type 2 Diabetes.

James E FramptonPubMed ↗Publisher ↗

No numbers read from the abstract.

54 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29946963